HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapeutic potential of a novel synthetic selectin blocker, OJ-R9188, in allergic dermatitis.

Abstract
1. We investigated the ability of a newly synthesized sugar derivative, OJ-R9188, [N-(2-tetradecylhexadecanoyl)-O-(L-alpha-fucofuranosyl)-D-seryl]-L-glutamic acid 1-methylamide 5-L-arginine salt, to block binding of selectins to their ligands in vitro and inhibit the infiltration of leukocytes in vivo. 2. OJ-R9188 prevented the binding of human E-, P- and L-selectin-IgG fusion proteins to immobilized sialyl Lewis(x) (sLe(x))-pentasaccharide glycolipid, with IC(50) values of 4.3, 1.3, and 1.2 microM, respectively. 3. In a mouse model of thioglycollate-induced peritonitis, OJ-R9188 at 10 mg kg(-1), i.v. inhibited neutrophil accumulation in the peritoneal cavity. In the IgE-mediated skin reaction, OJ-R9188 at 3 and 10 mg kg(-1), i.v. significantly inhibited extravasation of neutrophils and eosinophils into the inflammatory sites and at 10 mg kg(-1), i.v. also inhibited infiltration caused by picryl chloride-induced delayed-type hypersensitivity in mice. These results suggest that OJ-R9188 may be a useful selectin blocker, with activity against human and mouse E-, P- and L-selectins in vitro and in vivo, and that blocking selectin-sLe(x) binding is a promising strategy for the treatment of allergic skin diseases.
AuthorsA Ikegami-Kuzuhara, T Yoshinaka, H Ohmoto, Y Inoue, T Saito
JournalBritish journal of pharmacology (Br J Pharmacol) Vol. 134 Issue 7 Pg. 1498-504 (Dec 2001) ISSN: 0007-1188 [Print] England
PMID11724756 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • E-Selectin
  • Free Radical Scavengers
  • Immunoglobulin G
  • O-J-R9188
  • Oligosaccharides
  • P-Selectin
  • Polysaccharides
  • Recombinant Fusion Proteins
  • Selectins
  • Sialyl Lewis X Antigen
  • Thioglycolates
  • L-Selectin
  • Dexamethasone
  • fucoidan
  • Deoxyguanosine
  • Picryl Chloride
Topics
  • Animals
  • Anti-Inflammatory Agents (pharmacology)
  • Binding, Competitive (drug effects)
  • Deoxyguanosine (analogs & derivatives, pharmacology, therapeutic use)
  • Dermatitis (immunology, metabolism, prevention & control)
  • Dexamethasone (pharmacology)
  • Dose-Response Relationship, Drug
  • E-Selectin (metabolism)
  • Free Radical Scavengers (pharmacology, therapeutic use)
  • Humans
  • Hypersensitivity, Delayed (chemically induced, metabolism, prevention & control)
  • Immunoglobulin G (metabolism)
  • L-Selectin (metabolism)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Oligosaccharides (metabolism)
  • P-Selectin (metabolism)
  • Peritonitis (chemically induced, metabolism, prevention & control)
  • Picryl Chloride (administration & dosage)
  • Polysaccharides (pharmacology)
  • Recombinant Fusion Proteins (metabolism)
  • Selectins (metabolism)
  • Sialyl Lewis X Antigen
  • Thioglycolates (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: